NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis $60.72 -0.35 (-0.57%) As of 09:58 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Inspire Medical Systems Stock (NYSE:INSP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INSP alerts:Sign Up Key Stats Today's Range$60.01▼$61.0350-Day Range$41.28▼$64.0852-Week Range$38.91▼$147.03Volume8,911 shsAverage Volume1.11 million shsMarket Capitalization$1.76 billionP/E Ratio13.14Dividend YieldN/APrice Target$66.19Consensus RatingHold Company Overview Inspire Medical Systems, Inc. is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices. The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve. The device received FDA approval in 2014 and has since obtained CE mark authorization for marketing in Europe. Inspire collaborates with a network of accredited sleep centers and specialized physicians to identify eligible patients and provide training, support and follow-up care. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems serves markets across North America and Europe, with ongoing efforts to expand its commercial footprint in select international regions. The company is led by President and Chief Executive Officer Michael A. Moulder, supported by a management team with deep expertise in medical devices, regulatory affairs and commercial operations. Inspire remains focused on advancing its technology platform through clinical research, product enhancements and expanded physician education programs.AI Generated. May Contain Errors. Read More Inspire Medical Systems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreINSP MarketRank™: Inspire Medical Systems scored higher than 67% of companies evaluated by MarketBeat, and ranked 282nd out of 917 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingHold Consensus RatingInspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.21, and is based on 2 strong buy ratings, 3 buy ratings, 11 hold ratings, and 3 sell ratings.Upside/DownsideThe consensus price target for Inspire Medical Systems is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageInspire Medical Systems has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inspire Medical Systems' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth22.58% Earnings GrowthEarnings for Inspire Medical Systems are expected to grow by 22.58% in the coming year, from $1.24 to $1.52 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is 13.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.16.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is 13.25, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.01.Price to Earnings Growth RatioInspire Medical Systems has a PEG Ratio of 4.67. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 2.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Inspire Medical Systems' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.47% of the float of Inspire Medical Systems has been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 5.2.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 11.56%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. News and Social Media3.4 / 5News Sentiment1.44 News SentimentInspire Medical Systems has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Inspire Medical Systems this week, compared to 9 articles on an average week.MarketBeat Follows4 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $57,347.00 in company stock.Percentage Held by Insiders2.20% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inspire Medical Systems' insider trading history. Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INSP Stock News HeadlinesInspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference43 minutes ago | globenewswire.comInspire Medical Systems (NYSE:INSP) Insider Sells 963 SharesAugust 12, 2026 | insidertrades.comBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the digital dollar. They gave us the timeline… 2025 to 2030. We're in that window right now. Once the digital dollar launches, every transaction you make will be tracked. Your spending could be controlled. Your accounts could be frozen. Over 4,500 investors have already used this legal backdoor to hold assets CBDCs can't freeze and generate yields the Federal Reserve can't touch.August 26 at 1:00 AM | Decentralized Masters (Ad)Inspire Medical Systems (INSP) Q2 2026 Earnings Call TranscriptAugust 10, 2026 | finance.yahoo.com5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings CallAugust 10, 2026 | msn.comInspire Medical Systems, Inc. 2026 Q2 - Results - Earnings Call PresentationAugust 7, 2026 | seekingalpha.comWhy are Inspire Medical Systems (INSP) shares soaring todayAugust 4, 2026 | msn.comInspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 ResultsAugust 4, 2026 | benzinga.comSee More Headlines INSP Stock Analysis - Frequently Asked Questions How have INSP shares performed this year? Inspire Medical Systems' stock was trading at $92.20 at the start of the year. Since then, INSP stock has decreased by 33.6% and is now trading at $61.2310. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) posted its quarterly earnings results on Monday, August, 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.38. The firm's revenue for the quarter was down 7.6% compared to the same quarter last year. Read the conference call transcript. How will Inspire Medical Systems' stock buyback program work? Inspire Medical Systems' board initiated a stock buyback program on Monday, August 11th 2025, which authorizes the company to buy back $200,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 8.6% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's leadership believes its stock is undervalued. When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $101 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 6,750,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Inspire Medical Systems' top institutional investors include BlackRock Inc. (16.39%), Wellington Management Group LLP (8.24%), California State Teachers Retirement System (4.56%) and Assenagon Asset Management S.A. (3.00%). Insiders that own company stock include Timothy P Herbert, Richard Buchholz, Shawn Mccormick, Jason P Kelly, John Rondoni, Jerry C Griffin, Randy Ban and Myriam Curet. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). Company Calendar Last Earnings8/03/2026Today8/26/2026Next Earnings (Estimated)11/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 For the last 3 weeks, INSP's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:INSP CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,333Year Founded2007Price Target and Rating Average Price Target for Inspire Medical Systems$66.19 High Price Target$180.00 Low Price Target$39.00 Potential Upside/Downside+9.0%Consensus RatingHold Rating Score (0-4)2.21 Research Coverage19 Analysts Profitability EPS (Trailing Twelve Months)$4.62 Trailing P/E Ratio13.14 Forward P/E Ratio48.97 P/E Growth4.67Net Income$145.42 million Net Margins15.03% Pretax Margin7.72% Return on Equity8.64% Return on Assets7.45% Debt Debt-to-Equity RatioN/A Current Ratio8.55 Quick Ratio6.16 Sales & Book Value Annual Sales$911.98 million Price / Sales1.92 Cash Flow$2.83 per share Price / Cash Flow21.46 Book Value$28.56 per share Price / Book2.13Miscellaneous Outstanding Shares28,910,000Free Float28,274,000Market Cap$1.76 billion OptionableOptionable Beta0.70 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:INSP) was last updated on 8/26/2026 by MarketBeat.com Staff. From Our PartnersGold Explorer Sits Between Barrick’s Nevada GiantsBarrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldru...Wall Street Logic | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe AI company everyone's heard of goes publicYou don't need to be an AI expert to know the name Claude…. It's one of the handful of AI companies that's act...Crypto 101 Media | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INSP Stock Alerts